Orphan designation: Dabrafenib mesylate Treatment of glioma, 09/12/2020 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 5 December 2023 - 11:00

Orphan designation: Dabrafenib mesylate Treatment of glioma, 09/12/2020 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-20-2372

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters